Unknown

Dataset Information

0

Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase.


ABSTRACT: Cancer is a leading cause of death worldwide. The search for innovative therapeutic approaches is a principal focus of medical research. Vaccine strategies targeting a number of tumor-associated antigens are currently being evaluated. To date, none have garnered significant success. Purportedly, an immunosuppressive tumor microenvironment and the accumulation of regulatory T cells contribute to a lack of tumor vaccine efficacy. Aspartyl/asparaginyl β-hydroxylase (ASPH), a promising therapeutic target, is overexpressed in a variety of malignant tumors but is expressed negligibly in normal tissues. Computer analysis predicted that ASPH expresses four peptide sequences (epitopes) capable of stimulating regulatory T cell activity. The abolition of these putative regulatory T cell epitopes increased the CD4+ and CD8+ effector T cell responses to monocyte-derived dendritic cells pulsed with a modified, epitope-depleted version of ASPH in an ex vivo human lymphoid tissue-equivalent coculture system while simultaneously decreasing the overall number of FoxP3+ regulatory T cells. These findings suggest that the efficacy of all new vaccine candidates would profit from screening and eliminating potential tolerogenic regulatory T cell epitopes.

SUBMITTER: Wirsching S 

PROVIDER: S-EPMC9604227 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase.

Wirsching Sebastian S   Fichter Michael M   Cacicedo Maximiliano L ML   Landfester Katharina K   Gehring Stephan S  

International journal of molecular sciences 20221018 20


Cancer is a leading cause of death worldwide. The search for innovative therapeutic approaches is a principal focus of medical research. Vaccine strategies targeting a number of tumor-associated antigens are currently being evaluated. To date, none have garnered significant success. Purportedly, an immunosuppressive tumor microenvironment and the accumulation of regulatory T cells contribute to a lack of tumor vaccine efficacy. Aspartyl/asparaginyl β-hydroxylase (ASPH), a promising therapeutic t  ...[more]

Similar Datasets

| S-EPMC5878085 | biostudies-literature
| S-EPMC5361764 | biostudies-literature
| S-EPMC2893031 | biostudies-literature
| S-EPMC2818761 | biostudies-literature
| S-EPMC3625304 | biostudies-literature
| S-EPMC8484691 | biostudies-literature
| S-EPMC9249808 | biostudies-literature
| S-EPMC4449550 | biostudies-literature
| S-EPMC2893150 | biostudies-literature
| S-EPMC10539236 | biostudies-literature